Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 2,780

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

Stevens, Dennis L., Bisno, Alan L., Chambers, Henry F., Dellinger, E. Patchen, Goldstein, Ellie J. C., Gorbach, Sherwood L., Hirschmann, Jan V., Kaplan, Sheldon L., Montoya, Jose G., Wade, James C.·2014·Clinical Infectious Diseases
DOI 10.1093/cid/ciu296
Open this paper in CoChat — free account

Abstract

A panel of national experts was convened by the Infectious Diseases Society of America (IDSA) to update the 2005 guidelines for the treatment of skin and soft tissue infections (SSTIs). The panel's recommendations were developed to be concordant with the recently published IDSA guidelines for the treatment of methicillin-resistant Staphylococcus aureus infections. The focus of this guideline is the diagnosis and appropriate treatment of diverse SSTIs ranging from minor superficial infections to life-threatening infections such as necrotizing fasciitis. In addition, because of an increasing number of immunocompromised hosts worldwide, the guideline addresses the wide array of SSTIs that occur in this population. These guidelines emphasize the importance of clinical skills in promptly diagnosing SSTIs, identifying the pathogen, and administering effective treatments in a timely fashion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciu296

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 235

  1. Guyatt, 2008, Going from evidence to recommendations, BMJ, 336, 1049, 10.1136/bmj.39493.646875.AE · DOI · Paper page
  2. Edelsberg, 2009, Trends in US hospital admissions for skin and soft tissue infections, Emerg Infect Dis, 15, 1516, 10.3201/eid1509.081228 · DOI · Paper page
  3. Pallin, 2008, Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus, Ann Emerg Med, 51, 291, 10.1016/j.annemergmed.2007.12.004 · DOI · Paper page
  4. Pallin, 2009, Epidemiology of dermatitis and skin infections in United States physicians’ offices, 1993–2005, Clin Infect Dis, 49, 901, 10.1086/605434 · DOI
  5. Guyatt, 2008, Incorporating considerations of resources use into grading recommendations, BMJ, 336, 1170, 10.1136/bmj.39504.506319.80 · DOI · Paper page
  6. Chow, 2012, IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults, Clin Infect Dis, 54, e72, 10.1093/cid/cis370 · DOI · Paper page
  7. Hirschmann, 2002, Impetigo: etiology and therapy, Curr Clin Top Infect Dis, 22, 42
  8. Durupt, 2007, Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo, Br J Dermatol, 157, 1161, 10.1111/j.1365-2133.2007.08197.x · DOI
  9. Koning, 2008, Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial, Br J Dermatol, 158, 1077, 10.1111/j.1365-2133.2008.08485.x · DOI
  10. Wasserzug, 2009, A cluster of ecthyma outbreaks caused by a single clone of invasive and highly infective Streptococcus pyogenes, Clin Infect Dis, 48, 1213, 10.1086/597770 · DOI
  11. Duong, 2010, Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient, Ann Emerg Med, 55, 401, 10.1016/j.annemergmed.2009.03.014 · DOI
  12. Diven, 1998, Bacteriology of inflamed and uninflamed epidermal inclusion cysts, Arch Dermatol, 134, 49, 10.1001/archderm.134.1.49 · DOI
  13. Gaspari, 2011, A randomized controlled trial of incision and drainage versus ultrasonographically guided needle aspiration for skin abscesses and the effect of methicillin-resistant Staphylococcus aureus, Ann Emerg Med, 57, 483, 10.1016/j.annemergmed.2010.11.021 · DOI
  14. Macfie, 1977, The treatment of acute superficial abscesses: a prospective clinical trial, Br J Surg, 64, 264, 10.1002/bjs.1800640410 · DOI
  15. Llera, 1985, Treatment of cutaneous abscess: a double-blind clinical study, Ann Emerg Med, 14, 15, 10.1016/S0196-0644(85)80727-7 · DOI
  16. O'Malley, 2009, Routine packing of simple cutaneous abscesses is painful and probably unnecessary, Acad Emerg Med, 16, 470, 10.1111/j.1553-2712.2009.00409.x · DOI
  17. Rutherford, 1970, Antibiotics in surgical treatment of septic lesions, Lancet, 1, 1077, 10.1016/S0140-6736(70)92754-6 · DOI
  18. Schmitz, 2010, Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection, Ann Emerg Med, 56, 283, 10.1016/j.annemergmed.2010.03.002 · DOI
  19. Alikhan, 2009, Hidradenitis suppurativa: a comprehensive review, J Am Acad Dermatol, 60, 539, 10.1016/j.jaad.2008.11.911 · DOI · Paper page
  20. Humphries, 2010, Evaluation and management of pilonidal disease, Surg Clin North Am, 90, 113, 10.1016/j.suc.2009.09.006 · DOI
  21. Klempner, 1988, Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy, JAMA, 260, 2682, 10.1001/jama.1988.03410180090035 · DOI
  22. Raz, 1996, A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection, Arch Intern Med, 156, 1109, 10.1001/archinte.1996.00040041109010 · DOI
  23. Rahimian, 2007, Does nasal colonization or mupirocin treatment affect recurrence of methicillin-resistant Staphylococcus aureus skin and skin structure infections?, Infect Control Hosp Epidemiol, 28, 1415, 10.1086/523273 · DOI
  24. Ellis, 2007, Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial, Antimicrob Agents Chemother, 51, 3591, 10.1128/AAC.01086-06 · DOI
  25. Whitman, 2010, Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in Marine recruits: a cluster-randomized, double-blind, controlled effectiveness trial, Infect Control Hosp Epidemiol, 31, 1207, 10.1086/657136 · DOI
  26. Wiese-Posselt, 2007, Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002–2005, Clin Infect Dis, 44, e88, 10.1086/517503 · DOI
  27. Fritz, 2012, Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial, Clin Infect Dis, 54, 743, 10.1093/cid/cir919 · DOI
  28. Hirschmann, 2012, Lower limb cellulitis and its mimics: part I. Lower limb cellulitis, J Am Acad Dermatol, 67, 163 e1, 10.1016/j.jaad.2012.03.024 · DOI
  29. Dupuy, 1999, Risk factors for erysipelas of the leg (cellulitis): case-control study, BMJ, 318, 1591, 10.1136/bmj.318.7198.1591 · DOI · Paper page
  30. Bjornsdottir, 2005, Risk factors for acute cellulitis of the lower limb: a prospective case-control study, Clin Infect Dis, 41, 1416, 10.1086/497127 · DOI
  31. Perl, 1999, Cost-effectiveness of blood cultures for adult patients with cellulitis, Clin Infect Dis, 29, 1483, 10.1086/313525 · DOI
  32. Hook, 1986, Microbiologic evaluation of cutaneous cellulitis in adults, Arch Intern Med, 146, 295, 10.1001/archinte.1986.00360140113016 · DOI
  33. Sachs, 1990, The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults, Arch Intern Med, 150, 1907, 10.1001/archinte.1990.00390200091017 · DOI
  34. Leppard, 1985, The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas, Br J Dermatol, 112, 559, 10.1111/j.1365-2133.1985.tb15264.x · DOI
  35. Kielhofner, 1988, Influence of underlying disease process on the utility of cellulitis needle aspirates, Arch Intern Med, 148, 2451, 10.1001/archinte.1988.00380110091019 · DOI
  36. Sigurdsson, 1989, The etiology of bacterial cellulitis as determined by fine-needle aspiration, Scand J Infect Dis, 21, 537, 10.3109/00365548909037882 · DOI
  37. Newell, 1988, Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults, J Clin Microbiol, 26, 401, 10.1128/JCM.26.3.401-404.1988 · DOI
  38. Lebre, 1996, Value of fine-needle aspiration in infectious cellulitis, Arch Dermatol, 132, 842, 10.1001/archderm.1996.03890310134030 · DOI
  39. Lutomski, 1988, Microbiology of adult cellulitis, J Fam Pract, 26, 45
  40. Duvanel, 1989, Quantitative cultures of biopsy specimens from cutaneous cellulitis, Arch Intern Med, 149, 293, 10.1001/archinte.1989.00390020039008 · DOI
  41. Chartier, 1990, Erysipelas, Int J Dermatol, 29, 459, 10.1111/j.1365-4362.1990.tb04833.x · DOI
  42. Eriksson, 1996, Erysipelas: clinical and bacteriologic spectrum and serological aspects, Clin Infect Dis, 23, 1091, 10.1093/clinids/23.5.1091 · DOI
  43. Jeng, 2010, The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation, Medicine (Baltimore), 89, 217, 10.1097/MD.0b013e3181e8d635 · DOI
  44. Bernard, 1987, Early detection of streptococcal group antigens in skin samples by latex particle agglutination, Arch Dermatol, 123, 468, 10.1001/archderm.1987.01660280070025 · DOI
  45. Bernard, 1989, Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique, Arch Dermatol, 125, 779, 10.1001/archderm.1989.01670180051004 · DOI
  46. Semel, 1996, Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples, Clin Infect Dis, 23, 1162, 10.1093/clinids/23.5.1162 · DOI
  47. Baddour, 1984, Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs, JAMA, 251, 1049, 10.1001/jama.1984.03340320035023 · DOI
  48. Eriksson, 1999, Anal colonization of group G beta-hemolytic streptococci in relapsing erysipelas of the lower extremity, Clin Infect Dis, 29, 1319, 10.1086/313467 · DOI
  49. Jorup-Ronstrom, 1984, The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas, Infection, 12, 390, 10.1007/BF01645222 · DOI
  50. Hepburn, 2004, Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis, Arch Intern Med, 164, 1669, 10.1001/archinte.164.15.1669 · DOI
  51. Jenkins, 2010, Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship, Clin Infect Dis, 51, 895, 10.1086/656431 · DOI
  52. Pallin, 2013, Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial, Clin Infect Dis, 56, 1754, 10.1093/cid/cit122 · DOI
  53. Dall, 2005, Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy, Cutis, 75, 177
  54. Bergkvist, 1997, Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study, Scand J Infect Dis, 29, 377, 10.3109/00365549709011834 · DOI
  55. Bergkvist, 1998, Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up, Scand J Infect Dis, 30, 206, 10.1080/003655498750003708 · DOI
  56. McGee, 2008, Use of corticosteroids in treating infectious diseases, Arch Intern Med, 168, 1034, 10.1001/archinte.168.10.1034 · DOI
  57. Goettsch, 2006, Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands, J Eur Acad Dermatol Venereol, 20, 834, 10.1111/j.1468-3083.2006.01657.x · DOI
  58. Jorup-Ronstrom, 1987, Recurrent erysipelas: predisposing factors and costs of prophylaxis, Infection, 15, 105, 10.1007/BF01650206 · DOI
  59. McNamara, 2007, A predictive model of recurrent lower extremity cellulitis in a population-based cohort, Arch Intern Med, 167, 709, 10.1001/archinte.167.7.709 · DOI
  60. Lewis, 2006, Risk factors for recurrent lower extremity cellulitis in a U.S. Veterans Medical Center population, Am J Med Sci, 332, 304, 10.1097/00000441-200612000-00002 · DOI
  61. Karppelin, 2010, Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study, Clin Microbiol Infect, 16, 729, 10.1111/j.1469-0691.2009.02906.x · DOI
  62. Cox, 2006, Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up, Br J Dermatol, 155, 947, 10.1111/j.1365-2133.2006.07419.x · DOI
  63. Pavlotsky, 2004, Recurrent erysipelas: risk factors, J Dtsch Dermatol Ges, 2, 89, 10.1046/j.1439-0353.2004.03028.x · DOI
  64. Leclerc, 2007, Recurrent erysipelas: 47 cases, Dermatology, 214, 52, 10.1159/000096913 · DOI
  65. Sjoblom, 1993, Antibiotic prophylaxis in recurrent erysipelas, Infection, 21, 390, 10.1007/BF01728920 · DOI
  66. Kremer, 1991, Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections, J Infect, 22, 37, 10.1016/0163-4453(91)90898-3 · DOI
  67. Wang, 1997, Role of benzathine penicillin G in prophylaxis for recurrent streptococcal cellulitis of the lower legs, Clin Infect Dis, 25, 685, 10.1086/513752 · DOI
  68. Vignes, 2006, Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study, J Eur Acad Dermatol Venereol, 20, 818, 10.1111/j.1468-3083.2006.01648.x · DOI
  69. Thomas, 2013, Penicillin to prevent recurrent leg cellulitis, N Engl J Med, 368, 1695, 10.1056/NEJMoa1206300 · DOI
  70. Brennan, 1991, Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I, N Engl J Med, 324, 370, 10.1056/NEJM199102073240604 · DOI · Paper page
  71. Mangram, 1999, Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee, Infect Control Hosp Epidemiol, 20, 250, 10.1086/501620 · DOI · Paper page
  72. Gaynes, 2001, Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index, Clin Infect Dis, 33, S69, 10.1086/321860 · DOI · Paper page
  73. Dellinger, 2004, Approach to the patient with postoperative fever
  74. Burke, 1961, The effective period of preventive antibiotic action in experimental incisions and dermal lesions, Surgery, 50, 161
  75. Classen, 1992, The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection, N Engl J Med, 326, 281, 10.1056/NEJM199201303260501 · DOI · Paper page
  76. Stone, 1979, Prophylactic and preventive antibiotic therapy: timing, duration and economics, Ann Surg, 189, 691, 10.1097/00000658-197906000-00004 · DOI
  77. Dellinger, 1994, Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America, Clin Infect Dis, 18, 422, 10.1093/clinids/18.3.422 · DOI
  78. Bratzler, 2004, Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project, Clin Infect Dis, 38, 1706, 10.1086/421095 · DOI
  79. McDonald, 1998, Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review, Aust N Z J Surg, 68, 388, 10.1111/j.1445-2197.1998.tb04785.x · DOI
  80. Steinberg, 2009, Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors, Ann Surg, 250, 10, 10.1097/SLA.0b013e3181ad5fca · DOI
  81. van Kasteren, 2007, Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor, Clin Infect Dis, 44, 921, 10.1086/512192 · DOI
  82. Bartlett, 1982, Toxic shock syndrome associated with surgical wound infections, JAMA, 247, 1448, 10.1001/jama.1982.03320350052030 · DOI
  83. Raab, 1995, Postoperative toxic shock syndrome, Am J Orthop (Belle Mead NJ), 24, 130
  84. Mandell, 1995, Principles and practice of infectious diseases
  85. Cruse, 1988, Wound infections: epidemiology and clinical characteristics
  86. Lee, 1995, Surgical wound infections: surveillance for quality improvement
  87. DeLucia, 1993, Review for surgery: scientific principles and practice
  88. Townsend, 2001, The biologic basis of modern surgical practice
  89. Dellinger, 2012, Hospital Infections Chapter 817, 8
  90. Dellinger, 2001, Surgical infections and choice of antibiotics, 171
  91. Howard, 1988, Wound infections: epidemiology and clinical characteristics. Surgical infectious diseases
  92. Huizinga, 1986, The value of adjuvant systemic antibiotic therapy in localised wound infections among hospital patients: a comparative study, J Infect, 13, 11, 10.1016/S0163-4453(86)92118-3 · DOI
  93. Meislin, 1977, Cutaneous abscesses. Anaerobic and aerobic bacteriology and outpatient management, Ann Intern Med, 87, 145, 10.7326/0003-4819-87-2-145 · DOI
  94. Paydar, 2006, Inappropriate antibiotic use in soft tissue infections, Arch Surg, 141, 850, 10.1001/archsurg.141.9.850 · DOI
  95. Bobrow, 1997, Incision and drainage of cutaneous abscesses is not associated with bacteremia in afebrile adults, Ann Emerg Med, 29, 404, 10.1016/S0196-0644(97)70354-8 · DOI
  96. Brook, 1990, Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses, Arch Surg, 125, 1445, 10.1001/archsurg.1990.01410230039007 · DOI
  97. Meislin, 1986, Pathogen identification of abscesses and cellulitis, Ann Emerg Med, 15, 329, 10.1016/S0196-0644(86)80577-7 · DOI
  98. Dellinger, 2001, Postoperative wound infection
  99. Wyrick, 1970, Rare complications with intravenous hyperosmotic alimentation, JAMA, 211, 1697, 10.1001/jama.1970.03170100059017 · DOI
  100. Giuliano, 1977, Bacteriology of necrotizing fasciitis, Am J Surg, 134, 52, 10.1016/0002-9610(77)90283-5 · DOI · Paper page
  101. Stevens, 1989, Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A, N Engl J Med, 321, 1, 10.1056/NEJM198907063210101 · DOI · Paper page
  102. Chelsom, 1994, Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features, Lancet, 344, 1111, 10.1016/S0140-6736(94)90629-7 · DOI
  103. Anaya, 2007, Necrotizing soft-tissue infection: diagnosis and management, Clin Infect Dis, 44, 705, 10.1086/511638 · DOI · Paper page
  104. Zimbelman, 1999, Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection, Pediatr Infect Dis J, 18, 1096, 10.1097/00006454-199912000-00014 · DOI · Paper page
  105. Mulla, 2003, Invasive group A streptococcal infections in Florida, South Med J, 96, 968, 10.1097/01.SMJ.0000051060.95210.9A · DOI
  106. Tanz, 2004, Community-based surveillance in the united states of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons, Clin Infect Dis, 39, 1794, 10.1086/426025 · DOI
  107. Ardanuy, 2010, Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008), J Antimicrob Chemother, 65, 634, 10.1093/jac/dkq006 · DOI
  108. Noels, 2011, Catching up with important players in atherosclerosis: type I interferons and neutrophils, Curr Opin Lipidol, 22, 144, 10.1097/MOL.0b013e328344780b · DOI
  109. Jaggi, 2007, Macrolide resistance and emm type distribution of invasive pediatric group A streptococcal isolates: three-year prospective surveillance from a children's hospital, Pediatr Infect Dis J, 26, 253, 10.1097/01.inf.0000256761.10463.29 · DOI
  110. Stevens, 2003, Dilemmas in the treatment of invasive Streptococcus pyogenes infections, Clin Infect Dis, 37, 341, 10.1086/376652 · DOI
  111. Kaul, 1999, Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome—a comparative observational study. The Canadian Streptococcal Study Group, Clin Infect Dis, 28, 800, 10.1086/515199 · DOI
  112. Darenberg, 2003, Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial, Clin Infect Dis, 37, 333, 10.1086/376630 · DOI · Paper page
  113. Laucks, 1994, Fournier's gangrene, Surg Clin North Am, 74, 1339, 10.1016/S0039-6109(16)46485-6 · DOI
  114. Eke, 2000, Fournier's gangrene in Nigeria: a review of 21 consecutive patients, Int Surg, 85, 77
  115. Sissolak, 1994, Tropical pyomyositis, J Infect, 29, 121, 10.1016/S0163-4453(94)90530-4 · DOI
  116. Pannaraj, 2006, Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection, Clin Infect Dis, 43, 953, 10.1086/507637 · DOI
  117. Gafur, 2008, The impact of the current epidemiology of pediatric musculoskeletal infection on evaluation and treatment guidelines, J Pediatr Orthop, 28, 777, 10.1097/BPO.0b013e318186eb4b · DOI
  118. Crum, 2004, Bacterial pyomyositis in the United States, Am J Med, 117, 420, 10.1016/j.amjmed.2004.03.031 · DOI
  119. Garcia-Lechuz, 2007, Streptococcus pneumoniae skin and soft tissue infections: characterization of causative strains and clinical illness, Eur J Clin Microbiol Infect Dis, 26, 247, 10.1007/s10096-007-0283-7 · DOI
  120. Theodorou, 2007, MR imaging findings of pyogenic bacterial myositis (pyomyositis) in patients with local muscle trauma: illustrative cases, Emerg Radiol, 14, 89, 10.1007/s10140-007-0593-1 · DOI
  121. Turecki, 2010, Imaging of musculoskeletal soft tissue infections, Skeletal Radiol, 39, 957, 10.1007/s00256-009-0780-0 · DOI
  122. Browne, 2008, Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children, Pediatr Radiol, 38, 841, 10.1007/s00247-008-0888-8 · DOI
  123. Lin, 2008, Septic pulmonary emboli and bacteremia associated with deep tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus, J Clin Microbiol, 46, 1553, 10.1128/JCM.02379-07 · DOI
  124. Campbell, 2004, Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002, J Clin Microbiol, 42, 4050, 10.1128/JCM.42.9.4050-4053.2004 · DOI
  125. Weigelt, 2005, Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections, Antimicrob Agents Chemother, 49, 2260, 10.1128/AAC.49.6.2260-2266.2005 · DOI · Paper page
  126. Arbeit, 2004, The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections, Clin Infect Dis, 38, 1673, 10.1086/420818 · DOI
  127. File, 2012, Summary of ceftaroline fosamil clinical trials and clinical safety, Clin Infect Dis, S173, 10.1093/cid/cis559 · DOI
  128. Stevens, 2012, Life-threatening clostridial infections, Anaerobe, 18, 254, 10.1016/j.anaerobe.2011.11.001 · DOI
  129. Stevens, 1987, Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens, Antimicrob Agents Chemother, 31, 312, 10.1128/AAC.31.2.312 · DOI
  130. Stevens, 1987, Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens, J Infect Dis, 155, 220, 10.1093/infdis/155.2.220 · DOI
  131. Heimbach, 1993, Use of hyperbaric oxygen, Clin Infect Dis, 17, 239, 10.1093/clinids/17.2.239 · DOI
  132. Goldstein, 1980, Dog bite wounds and infection: a prospective clinical study, Ann Emerg Med, 9, 508, 10.1016/S0196-0644(80)80188-0 · DOI
  133. Goldstein, 1988, Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds, Antimicrob Agents Chemother, 32, 1143, 10.1128/AAC.32.8.1143 · DOI
  134. Kroger, 2006, General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 55, 1
  135. Goldstein, 2001, Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections, J Antimicrob Chemother, 48, 641, 10.1093/jac/48.5.641 · DOI
  136. Brakenbury, 1989, A comparative double blind study of amoxycillin/clavulanate vs placebo in the prevention of infection after animal bites, Arch Emerg Med, 6, 251, 10.1136/emj.6.4.251 · DOI
  137. Talan, 2003, Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments, Clin Infect Dis, 37, 1481, 10.1086/379331 · DOI
  138. Pascual, 2003, Tetanus surveillance—United States, 1998–2000, MMWR Surveill Summ, 52, 1
  139. Goldstein, 1992, Bite wounds and infection, Clin Infect Dis, 14, 633, 10.1093/clinids/14.3.633 · DOI · Paper page
  140. Gouin, 2001, Office management of minor wounds, Can Fam Physician, 47, 769
  141. Callaham, 1980, Prophylactic antibiotics in common dog bite wounds: a controlled study, Ann Emerg Med, 9, 410, 10.1016/S0196-0644(80)80153-3 · DOI
  142. Elenbaas, 1982, Prophylactic oxacillin in dog bite wounds, Ann Emerg Med, 11, 248, 10.1016/S0196-0644(82)80093-0 · DOI
  143. Dire, 1992, Prophylactic oral antibiotics for low-risk dog bite wounds, Pediatr Emerg Care, 8, 194, 10.1097/00006565-199208000-00005 · DOI
  144. Dire, 1992, Emergency management of dog and cat bite wounds, Emerg Med Clin North Am, 10, 719, 10.1016/S0733-8627(20)30681-7 · DOI
  145. Cummings, 1994, Antibiotics to prevent infection in patients with dog bite wounds: a meta-analysis of randomized trials, Ann Emerg Med, 23, 535, 10.1016/S0196-0644(94)70073-7 · DOI
  146. Singer, 2008, Current management of acute cutaneous wounds, N Engl J Med, 359, 1037, 10.1056/NEJMra0707253 · DOI
  147. Medeiros, 2001, Antibiotic prophylaxis for mammalian bites, Cochrane Database Syst Rev, 10.1002/14651858.CD001738 · DOI
  148. Goldstein, 1978, Bacteriology of human and animal bite wounds, J Clin Microbiol, 8, 667, 10.1128/jcm.8.6.667-672.1978 · DOI
  149. Abrahamian, 2011, Microbiology of animal bite wound infections, Clin Microbiol Rev, 24, 231, 10.1128/CMR.00041-10 · DOI · Paper page
  150. Goldstein, 1988, Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida, Antimicrob Agents Chemother, 32, 213, 10.1128/AAC.32.2.213 · DOI
  151. Goldstein, 1999, Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans, Antimicrob Agents Chemother, 43, 1469, 10.1128/AAC.43.6.1469 · DOI
  152. Stevens, 1979, Antibiotic susceptibilities of human isolates of Pasteurella multocida, Antimicrob Agents Chemother, 16, 322, 10.1128/AAC.16.3.322 · DOI
  153. No authors listed, 1991, Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory Committee (ACIP), MMWR Recomm Rep, 40, 1
  154. Bowie, 1996, Tetanus toxoid for adults—too much of a good thing, Lancet, 348, 1185, 10.1016/S0140-6736(05)65476-1 · DOI
  155. Zook, 1980, Successful treatment protocol for canine fang injuries, J Trauma, 20, 243, 10.1097/00005373-198003000-00010 · DOI
  156. Schultz, 1972, The treatment of dog bite injuries, especially those of the face, Plast Reconstr Surg, 49, 494, 10.1097/00006534-197205000-00003 · DOI
  157. Stucker, 1990, Management of animal and human bites in the head and neck, Arch Otolaryngol Head Neck Surg, 116, 789, 10.1001/archotol.1990.01870070037006 · DOI
  158. Palmer, 1983, Dog bites of the face: a 15 year review, Br J Plast Surg, 36, 315, 10.1016/S0007-1226(83)90051-6 · DOI
  159. Inglesby, 1999, Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense, JAMA, 281, 1735, 10.1001/jama.281.18.1735 · DOI · Paper page
  160. Dixon, 1999, Anthrax, N Engl J Med, 341, 815, 10.1056/NEJM199909093411107 · DOI · Paper page
  161. No authors listed, 2001, Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001, MMWR Morb Mortal Wkly Rep, 50, 909
  162. Bass, 1998, Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease, Pediatr Infect Dis J, 17, 447, 10.1097/00006454-199806000-00002 · DOI
  163. Ramirez Ramirez, 1996, Bacillary angiomatosis: microbiology, histopathology, clinical presentation, diagnosis and management, Bol Asoc Med P R, 88, 46
  164. Andrychowski, 2012, Empyema in spinal canal in thoracic region, abscesses in paravertebral space, spondylitis: in clinical course of zoonosis Erysipelothrix rhusiopathiae, Eur Spine J, 21, 557, 10.1007/s00586-012-2289-9 · DOI
  165. Brooke, 1999, Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen, J Med Microbiol, 48, 789, 10.1099/00222615-48-9-789 · DOI · Paper page
  166. Estes, 2010, Present and future therapeutic strategies for melioidosis and glanders, Expert Rev Anti Infect Ther, 8, 325, 10.1586/eri.10.4 · DOI
  167. Srinivasan, 2001, Glanders in a military research microbiologist, N Engl J Med, 345, 256, 10.1056/NEJM200107263450404 · DOI
  168. Perry, 1997, Yersinia pestis—etiologic agent of plague, Clin Microbiol Rev, 10, 35, 10.1128/CMR.10.1.35 · DOI · Paper page
  169. Maurin, 2011, Human tularemia in France, 2006–2010, Clin Infect Dis, 53, e133, 10.1093/cid/cir612 · DOI
  170. Kroshinsky, 2007, Approach to the patient with presumed cellulitis, Semin Cutan Med Surg, 26, 168, 10.1016/j.sder.2007.09.002 · DOI
  171. Lopez, 2001, Dermatologic infections in the immunocompromised (non-HIV) host, Infect Dis Clin North Am, 15, 671, 10.1016/S0891-5520(05)70164-1 · DOI
  172. Pizzo, 1999, Fever in immunocompromised patients, N Engl J Med, 341, 893, 10.1056/NEJM199909163411207 · DOI
  173. Podjasek, 2012, Cutaneous small-vessel vasculitis associated with solid organ malignancies: the Mayo Clinic experience, 1996 to 2009, J Am Acad Dermatol, 66, e55, 10.1016/j.jaad.2010.09.732 · DOI
  174. Gafter-Gvili, 2012, Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy, Cochrane Database Syst Rev, 1
  175. Montoya, 2001, Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center, Clin Infect Dis, 33, 629, 10.1086/322733 · DOI · Paper page
  176. Lamoth, 2010, Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia, J Clin Microbiol, 48, 3510, 10.1128/JCM.00147-10 · DOI
  177. Petti, 2007, Detection and identification of microorganisms by gene amplification and sequencing, Clin Infect Dis, 44, 1108, 10.1086/512818 · DOI · Paper page
  178. Schuetz, 2013, Invasive fungal infections: biomarkers and molecular approaches to diagnosis, Clin Lab Med, 33, 505, 10.1016/j.cll.2013.03.009 · DOI
  179. Freifeld, 2011, Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America, Clin Infect Dis, 52, e56, 10.1093/cid/cir073 · DOI · Paper page
  180. Lingaratnam, 2011, Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering Committee, Intern Med J, 41, 75, 10.1111/j.1445-5994.2010.02338.x · DOI
  181. Segal, 2008, Prevention and treatment of cancer-related infections, J Natl Compr Canc Netw, 6, 122, 10.6004/jnccn.2008.0013 · DOI
  182. Tomblyn, 2009, Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface, Bone Marrow Transplant, 44, 453, 10.1038/bmt.2009.254 · DOI · Paper page
  183. Walsh, 2008, Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America, Clin Infect Dis, 46, 327, 10.1086/525258 · DOI · Paper page
  184. Mermel, 2009, Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America, Clin Infect Dis, 49, 1, 10.1086/599376 · DOI · Paper page
  185. Legrand, 2012, Survival in neutropenic patients with severe sepsis or septic shock, Crit Care Med, 40, 43, 10.1097/CCM.0b013e31822b50c2 · DOI
  186. Paesmans, 2011, Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?, Support Care Cancer, 19, 1001, 10.1007/s00520-010-0925-7 · DOI
  187. Klastersky, 2006, Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications, J Clin Oncol, 24, 4129, 10.1200/JCO.2005.03.9909 · DOI
  188. Lanoix, 2012, Bacterial lung sepsis in patients with febrile neutropenia, Curr Opin Pulm Med, 18, 175, 10.1097/MCP.0b013e328351f8e8 · DOI
  189. Mebis, 2010, Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change, Infect Drug Resist, 3, 53, 10.2147/IDR.S11413 · DOI
  190. Nordmann, 2009, The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria, Lancet Infect Dis, 9, 228, 10.1016/S1473-3099(09)70054-4 · DOI · Paper page
  191. Johnston, 2001, Deep soft tissue infections in the neutropenic pediatric oncology patient, J Pediatr Hematol Oncol, 23, 443, 10.1097/00043426-200110000-00010 · DOI
  192. Reich, 2004, Nonpseudomonal ecthyma gangrenosum, J Am Acad Dermatol, 50, S114, 10.1016/j.jaad.2003.09.019 · DOI
  193. Wade, 2006, Viral infections in patients with hematological malignancies, Hematology Am Soc Hematol Educ Program, 2006, 368, 10.1182/asheducation-2006.1.368 · DOI
  194. Pizzo, 1993, Management of fever in patients with cancer and treatment-induced neutropenia, N Engl J Med, 328, 1323, 10.1056/NEJM199305063281808 · DOI
  195. Kosmidis, 2012, Management of gram-positive bacterial infections in patients with cancer, Leuk Lymphoma, 53, 8, 10.3109/10428194.2011.602770 · DOI
  196. Tattevin, 2006, What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized?, Clin Infect Dis, 42, 1813, 10.1086/504431 · DOI
  197. Jaksic, 2006, Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer, Clin Infect Dis, 42, 597, 10.1086/500139 · DOI
  198. Freifeld, 1999, A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy, N Engl J Med, 341, 305, 10.1056/NEJM199907293410501 · DOI · Paper page
  199. Freifeld, 2011, No place like home? Outpatient management of patients with febrile neutropenia and low risk, J Clin Oncol, 29, 3952, 10.1200/JCO.2011.37.5758 · DOI
  200. Spellberg, 2012, Combination therapy for mucormycosis: why, what, and how?, Clin Infect Dis, 54, S73, 10.1093/cid/cir885 · DOI

200 of 235 shown

Cited by

See all 2,780

Metadata

Authors
Stevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C.
Venue
Clinical Infectious Diseases
Publisher
Oxford University Press (OUP)
Published
2014-07-15
Volume
59
Issue
2
Pages
e10-e52
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
DOI
10.1093/cid/ciu296
OpenAlex
W2136609531
Cited by
2,780
References
11
FWCI
191.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.